Michael Carolan

Direttore Tecnico/Scientifico/R&S presso The Walter & Eliza Hall Institute of Medical Research

Consumer Services

Commercial Services

Profilo

Michael Carolan is currently the Chief Information Officer at The Walter & Eliza Hall Institute of Medical Research.
He has a graduate degree and an MBA from The Open University, and an undergraduate degree from The University of Hull.

Posizioni attive di Michael Carolan

Società	Posizione	Inizio
The Walter & Eliza Hall Institute of Medical Research The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia.	Direttore Tecnico/Scientifico/R&S	-

Tutte le posizioni attive di Michael Carolan

Formazione di Michael Carolan

The University of Hull	Undergraduate Degree
The Open University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Michael Carolan

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
The Walter & Eliza Hall Institute of Medical Research The Walter & Eliza Hall Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services The Walter and Eliza Hall Institute of Medical Research provides medical research services. It undertakes research in a range of areas, preventing and treating diseases including breast, ovarian and blood cancers, type 1 diabetes, rheumatoid arthritis, coeliac disease and malaria. The firm’s research areas include bioinformatics, cancer biology, cell death, cell signaling, clinical translation, epigenetics, genomics, immunology, and inflammation and vaccine development. The company was founded in 1915 and is headquartered in Melbourne, Australia.	Commercial Services